494 related articles for article (PubMed ID: 25950156)
41. Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies.
Govender P; Riedel T; Dyson PJ; Smith GS
Dalton Trans; 2016 Jun; 45(23):9529-39. PubMed ID: 27193373
[TBL] [Abstract][Full Text] [Related]
42. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
[TBL] [Abstract][Full Text] [Related]
43. Biotin-tagged platinum(iv) complexes as targeted cytostatic agents against breast cancer cells.
Muhammad N; Sadia N; Zhu C; Luo C; Guo Z; Wang X
Chem Commun (Camb); 2017 Sep; 53(72):9971-9974. PubMed ID: 28831477
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives.
Serratrice M; Maiore L; Zucca A; Stoccoro S; Landini I; Mini E; Massai L; Ferraro G; Merlino A; Messori L; Cinellu MA
Dalton Trans; 2016 Jan; 45(2):579-90. PubMed ID: 26609781
[TBL] [Abstract][Full Text] [Related]
45. A new bis-pyrazolylpyridine ruthenium(III) complex as a potential anticancer drug:
Lazić D; Scheurer A; Ćoćić D; Milovanović J; Arsenijević A; Stojanović B; Arsenijević N; Milovanović M; Rilak Simović A
Dalton Trans; 2021 Jun; 50(22):7686-7704. PubMed ID: 33982702
[TBL] [Abstract][Full Text] [Related]
46. Pt(II) complexes with (N,N') or (C,N,E)(-) (E=N,S) ligands: cytotoxic studies, effect on DNA tertiary structure and structure-activity relationships.
Albert J; Bosque R; Crespo M; Granell J; López C; Cortés R; Gonzalez A; Quirante J; Calvis C; Messeguer R; Baldomà L; Badia J; Cascante M
Bioorg Med Chem; 2013 Jul; 21(14):4210-7. PubMed ID: 23735827
[TBL] [Abstract][Full Text] [Related]
47. Anti-adhesive action of novel ruthenium(II) chlorophenyl terpyridine complexes with a high affinity for double-stranded DNA: in vitro and in silico.
Masnikosa R; Milutinović MM; Crnolatac I; Tot A; Veličković S; Bojić-Trbojević Ž; Rilak-Simović A
J Inorg Biochem; 2020 Jul; 208():111090. PubMed ID: 32389890
[TBL] [Abstract][Full Text] [Related]
48. A novel ruthenium(II)-polypyridyl complex inhibits cell proliferation and induces cell apoptosis by impairing DNA damage repair.
Yang Q; Zhang Z; Mei W; Sun F
J Chemother; 2014 Aug; 26(4):235-42. PubMed ID: 24070188
[TBL] [Abstract][Full Text] [Related]
49. Multifunctional DNA interactions of Ru-Pt mixed metal supramolecular complexes with substituted terpyridine ligands.
Jain A; Wang J; Mashack ER; Winkel BS; Brewer KJ
Inorg Chem; 2009 Oct; 48(19):9077-84. PubMed ID: 19739630
[TBL] [Abstract][Full Text] [Related]
50. Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.
Huang H; Zhang P; Chen Y; Ji L; Chao H
Dalton Trans; 2015 Sep; 44(35):15602-10. PubMed ID: 26245234
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand.
Riccardi C; Capasso D; Rozza GM; Platella C; Montesarchio D; Di Gaetano S; Marzo T; Pratesi A; Messori L; Roviello GN; Musumeci D
J Inorg Biochem; 2020 Feb; 203():110868. PubMed ID: 31837618
[TBL] [Abstract][Full Text] [Related]
52. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
Štarha P; Trávníček Z; Pazderová L; Dvořák Z
J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, characterization and biological evaluation of labile intercalative ruthenium(ii) complexes for anticancer drug screening.
Huang H; Zhang P; Chen Y; Qiu K; Jin C; Ji L; Chao H
Dalton Trans; 2016 Aug; 45(33):13135-45. PubMed ID: 27294337
[TBL] [Abstract][Full Text] [Related]
54. Influence of diimine bidentate ligand in the nitrosyl and nitro terpyridine ruthenium complex on the HSA/DNA interaction and antiviral activity.
Bessas NC; Christine de Souza Arantes E; Cassani NM; Aquino Ruiz UE; Santos IA; Silva Martins DO; Costa Oliveira AL; Antoniucci GA; de Oliveira AHC; DeFreitas-Silva G; Gomes Jardim AC; Galvão de Lima R
Nitric Oxide; 2024 Jun; 147():26-41. PubMed ID: 38614230
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
[TBL] [Abstract][Full Text] [Related]
56. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
[TBL] [Abstract][Full Text] [Related]
58. Ru(II)-based complexes with N-(acyl)-N',N'-(disubstituted)thiourea ligands: Synthesis, characterization, BSA- and DNA-binding studies of new cytotoxic agents against lung and prostate tumour cells.
Correa RS; de Oliveira KM; Delolo FG; Alvarez A; Mocelo R; Plutin AM; Cominetti MR; Castellano EE; Batista AA
J Inorg Biochem; 2015 Sep; 150():63-71. PubMed ID: 26160296
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
60. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
